ATE114473T1 - Ausrüstung für die verwendung bei der behandlung von osteoporose. - Google Patents

Ausrüstung für die verwendung bei der behandlung von osteoporose.

Info

Publication number
ATE114473T1
ATE114473T1 AT90200433T AT90200433T ATE114473T1 AT E114473 T1 ATE114473 T1 AT E114473T1 AT 90200433 T AT90200433 T AT 90200433T AT 90200433 T AT90200433 T AT 90200433T AT E114473 T1 ATE114473 T1 AT E114473T1
Authority
AT
Austria
Prior art keywords
regimen
daily doses
osteoporosis
treatment
bone
Prior art date
Application number
AT90200433T
Other languages
English (en)
Inventor
Vernon Albert Uchtman
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE114473T1 publication Critical patent/ATE114473T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/16—Fluorine compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
  • Surgical Instruments (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Debugging And Monitoring (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Processing Of Solid Wastes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90200433T 1984-04-30 1985-04-25 Ausrüstung für die verwendung bei der behandlung von osteoporose. ATE114473T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60554084A 1984-04-30 1984-04-30
US68456084A 1984-12-21 1984-12-21

Publications (1)

Publication Number Publication Date
ATE114473T1 true ATE114473T1 (de) 1994-12-15

Family

ID=27084976

Family Applications (2)

Application Number Title Priority Date Filing Date
AT85200650T ATE66608T1 (de) 1984-04-30 1985-04-25 Ausruestung fuer die behandlung der osteoporose.
AT90200433T ATE114473T1 (de) 1984-04-30 1985-04-25 Ausrüstung für die verwendung bei der behandlung von osteoporose.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT85200650T ATE66608T1 (de) 1984-04-30 1985-04-25 Ausruestung fuer die behandlung der osteoporose.

Country Status (12)

Country Link
EP (2) EP0381296B1 (de)
JP (1) JPH0655675B2 (de)
AT (2) ATE66608T1 (de)
AU (1) AU584611B2 (de)
CA (1) CA1277233C (de)
DE (2) DE3587956T2 (de)
DK (1) DK173735B1 (de)
FI (1) FI851686A7 (de)
HK (1) HK46694A (de)
IE (1) IE66497B1 (de)
NZ (1) NZ211925A (de)
PH (1) PH22622A (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis
GR861167B (en) * 1985-05-02 1986-09-30 Research Corp Bone targeted inhibitors of carbonic anhydrase
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
CA2035179C (en) * 1990-01-31 2001-08-14 Gerald S. Brenner Pharmaceutical compositions containing insoluble salts of bisphosphonic acids
DE69201725T2 (de) * 1991-02-26 1996-04-18 Procter & Gamble Pharmaceuticals, Inc. (An Ohio Corp.), Norwich, N.Y. Behandlungsmethoden für osteoporose.
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
EP0779812A4 (de) * 1994-09-09 1997-09-10 Procter & Gamble Verfahren zur behandlung von osteoporose unter verwendung von knochenaktiven phosphonaten und parathormon
FR2727629A1 (fr) * 1994-12-06 1996-06-07 Sanofi Sa Trousse pour cycle de traitement de l'osteoporose
JP3796693B2 (ja) * 1994-12-28 2006-07-12 ガドール エス アー オルパドロネートからなる骨塊同化組成物
IL120270A0 (en) * 1996-02-28 1997-06-10 Pfizer Combination therapy to treat osteoporosis
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
DE19629816A1 (de) * 1996-07-24 1998-01-29 Hoechst Ag Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19629817A1 (de) * 1996-07-24 1998-01-29 Hoechst Ag Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19653647A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
AR013994A1 (es) * 1998-10-30 2001-01-31 Gador Sa Procedimiento y preparaciones que modulan selectivamente la funcion del osteoblasto para la prevencion y tratamiento de las osteopatias fragilizantes.
WO2000028982A2 (en) * 1998-11-19 2000-05-25 The Board Of Trustees For The University Of Arkansas Increasing bone strength with selected bisphosphonates
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
IL145124A0 (en) * 1999-03-05 2002-06-30 Procter & Gamble Methods of increasing bone volume using non-naturally-occuring fp selective agonists and antiresorptive compounds
CA2410201C (en) 2000-06-20 2010-10-26 Novartis Ag Zoledronic acid or salts thereof for use in the treatment of conditions of abnormally increased bone turnover
EP1317247A1 (de) * 2000-09-13 2003-06-11 The Procter & Gamble Company Kosmetisches verfahren zur behandlung der haut und/oder haare
US20030080191A1 (en) 2001-10-26 2003-05-01 Allen Lubow Method and apparatus for applying bar code information to products during production
WO2003052681A1 (en) 2001-12-17 2003-06-26 International Barcode Corporation Double-sided bar code doubling as a single bar code
EP3345607B1 (de) 2006-12-29 2022-10-26 Ossifi-Mab LLC Verfahren zur veränderung des knochenwachstums durch verabreichung von sost- oder wise-antagonisten oder agonisten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US4330537A (en) * 1977-12-07 1982-05-18 The Procter & Gamble Company Compositions for inhibiting mobilization of calcium phosphate in animal tissue
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
AU569391B2 (en) * 1984-04-30 1988-01-28 Procter & Gamble Company, The Treating osteoporosis
AU568433B2 (en) * 1984-04-30 1987-12-24 Procter & Gamble Company, The Treating osteoporosis

Also Published As

Publication number Publication date
CA1277233C (en) 1990-12-04
EP0162510B1 (de) 1991-08-28
JPH0655675B2 (ja) 1994-07-27
JPS6133117A (ja) 1986-02-17
FI851686A0 (fi) 1985-04-29
AU584611B2 (en) 1989-06-01
DK173735B1 (da) 2001-08-20
NZ211925A (en) 1989-01-06
EP0162510A1 (de) 1985-11-27
IE66497B1 (en) 1996-01-10
EP0381296A1 (de) 1990-08-08
PH22622A (en) 1988-10-28
DK193585A (da) 1985-10-31
ATE66608T1 (de) 1991-09-15
HK46694A (en) 1994-05-20
DE3587956T2 (de) 1995-05-24
FI851686L (fi) 1985-10-31
AU4176985A (en) 1985-11-07
DE3583887D1 (de) 1991-10-02
IE851084L (en) 1985-10-30
DE3587956D1 (de) 1995-01-12
FI851686A7 (fi) 1985-10-31
EP0381296B1 (de) 1994-11-30
DK193585D0 (da) 1985-04-30

Similar Documents

Publication Publication Date Title
DE3587956D1 (de) Ausrüstung für die Verwendung bei der Behandlung von Osteoporose.
DE3579126D1 (de) Minocylin in stabiler form enthaltendes mittel zur behandlung periodontaler erkrankungen.
MY102586A (en) Medicaments for paf acether induced maladies
IT1130252B (it) Metodo per l'eliminazione dell'interferenza da biliribuna nel dosaggio di perossido di idrigeno mediante una reazione di trinder modificata
ES2058124T3 (es) Aerosoles que contienen liposomas y metodo para su preparacion.
DE3779149D1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
ES2000880A6 (es) Un procedimiento para preparar n-(1(s)-etoxicarbonil-3-fenilpropil)-l-alanil-l-prolina
FI873363A0 (fi) Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet.
ATE157251T1 (de) Verwendung von inositoltriphosphat zur behandlung von entzündungen
ES522918A0 (es) Procedimiento y aparato para el analisis de compuestos terapeuticos. otrosi.- se hace constar que el procedimiento y aparato que se reivindican en esta patente son inseparables y constituyen un solo objeto.
DE3484055D1 (de) Verwendung von ubidecarenon zur herstellung eines medikaments zur behandlung von durch radiotherapie hervorgerufenen geschwueren.
ES270679U (es) Transmision de correa dentada y poleas dentadas.
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
ES2051695T3 (es) Tratamiento de la trombosis que contiene un fibrinolitico y un analogo de carbaciclina.
GR3004103T3 (de)
ATE64300T1 (de) Wirkstoffe zur anwendung bei der behandlung von tumoren.
HU9201799D0 (en) New 2-amino-5-ciano-1,4-dihydropiridine-derivatives, process for their use and their use as medicaments
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
JO1521B1 (en) Amino Propene compounds are substituted amides, practical for their preparation, the agents they contain, their use, and new intermediate compounds produced in the preparation process.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
NO874241D0 (no) Terapeutisk aktive salter.
GR3006434T3 (de)
ATE147988T1 (de) Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände
IE831131L (en) Use of a cholecalciferol derivative

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee